Company Number: 13121579

Analysis Date: 2025-07-20 14:11 UTC

1. Risk Rating: HIGH
   The company exhibits significant solvency risk as evidenced by large and increasing net current liabilities and negative shareholders’ funds over multiple years. The current liabilities vastly exceed current assets, highlighting liquidity concerns. The company is in a pre-revenue stage with ongoing losses funded by shareholder loans and credit facilities, indicating operational instability until revenue generation commences.

2. Key Concerns:

• Severe Negative Net Current Assets & Net Assets: The company’s net current assets were approximately -£3.36 million and net assets around -£3.36 million as of June 2024, worsening year-on-year, suggesting an inability to meet short-term obligations without external financing.
• Pre-Revenue Status with Ongoing Trading Losses: The company has not yet generated sales revenue and continues to incur losses (~£1.2 million annually), dependent on interest-free loans and extended credit facilities, which may not be sustainable long term.
• Uncertainty in Inward Investment and Development Progress: Delays in securing the R&D development site and slow take-up of equity/bond investment raise concerns about the company’s ability to fund its business plan and commence operations in line with strategic timelines.

3. Positive Indicators:

• Active Strategic Planning and Fundraising Efforts: The company maintains a clear 5-year business plan and is actively pursuing revised strategic plans, investor engagement, and alternative financing routes, including equity participation and bond issuance.
• Experienced Management and Governance: Directors have demonstrated compliance with statutory duties, and the company has professional auditors, solicitors, and advisors engaged, indicating sound governance practices.
• Successful R&D Tax Relief Application: The company has secured R&D tax relief for innovative work on its ‘flying factory,’ which could improve cash flow in future periods.

4. Due Diligence Notes:

• Review Loan and Credit Facility Agreements: Examine terms and sustainability of interest-free shareholder loans and credit extended by related parties to assess risk of funding withdrawal.
• Assess Progress on Site Acquisition and Project Milestones: Validate status and timelines for the R&D site acquisition and alternative land options to understand operational feasibility.
• Evaluate Investor Pipeline and Fundraising Documentation: Scrutinize investor engagement materials, response rates, and likelihood of successful capital raising to support business continuity.
• Confirm No Director Disqualifications or Governance Issues: Although none are apparent, verify director conduct records and compliance history to rule out potential governance risks.
• Analyze Cash Flow Forecasts and Break-even Projections: Review updated forecasts tied to the revised 5-year business plan to gauge realistic timelines for achieving sales and profitability.